Chin-thinner winner Kythera grabs $37 million for Phase III trials in US
20 September 2011
Nancy Faigen
Please Login to read the full article.
20 September 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Fibrocell acquires rights from UCLA; seeks a lead on adult mesenchymal stem cells from dermal skin cells
- Kythera keeps chin up in aesthetic market with positive data on submental fat reducer
- Allos buy could be silver lining for Spectrum after cancer drug setback
- Pearl seeks partner for COPD LAMA after positive Phase IIb results
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
